• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hypersensitivity reactions and enzyme replacement therapy: Outcomes and safety of rapid desensitization in 1,008 infusions.

作者信息

Aranda Carolina Sanchez, Aun Marcelo Vivolo, Souza Carolina Fischinger Moura de, Pinto Louise Lapagesse de Camargo, Porras-Hurtado Gloria Liliana, Salgado Omar Francisco Sierra, Arantes Rodrigo Rezende, Martins Ana Maria, Solé Dirceu

机构信息

Department of Pediatrics, Escola Paulista de Medicina-Federal University of São Paulo (EPM-UNIFESP), SP, Brazil and Reference Center on Inborn Errors of Metabolism (CREIM) of the Department of Pediatrics, EPM-UNIFESP.

Albert Einstein Israeli Faculty of Health Sciences, Brazil and Department of Internal Medicine, Faculty of Medicine, University of São Paulo, SP, Brazil.

出版信息

J Allergy Clin Immunol Pract. 2022 Mar;10(3):870-873.e1. doi: 10.1016/j.jaip.2021.10.052. Epub 2021 Nov 4.

DOI:10.1016/j.jaip.2021.10.052
PMID:34742930
Abstract
摘要

相似文献

1
Hypersensitivity reactions and enzyme replacement therapy: Outcomes and safety of rapid desensitization in 1,008 infusions.超敏反应与酶替代疗法：1008次输注中快速脱敏的结果与安全性
J Allergy Clin Immunol Pract. 2022 Mar;10(3):870-873.e1. doi: 10.1016/j.jaip.2021.10.052. Epub 2021 Nov 4.
2
Shortened desensitization leading to a 2-year enzyme replacement therapy with elosulfase alfa.缩短脱敏疗程，从而开始为期两年的阿加糖酶α酶替代疗法。
Ann Allergy Asthma Immunol. 2021 Aug;127(2):261-262. doi: 10.1016/j.anai.2021.04.040. Epub 2021 May 14.
3
Hypersensitivity reaction during enzyme replacement therapy in lysosomal storage disorders. A systematic review of desensitization strategies.溶酶体贮积症酶替代治疗中的过敏反应。脱敏策略的系统评价。
Pediatr Allergy Immunol. 2023 Jun;34(6):e13981. doi: 10.1111/pai.13981.
4
Successful sebelipase alfa desensitization in a pediatric patient.一名儿科患者成功进行了 sebelipase alfa 脱敏治疗。
J Allergy Clin Immunol Pract. 2019 Feb;7(2):732-733. doi: 10.1016/j.jaip.2018.07.012. Epub 2018 Jul 24.
5
Successful rapid desensitization to imiglucerase in an adult patient with Gaucher disease and documented IgE-mediated hypersensitivity.一名患有戈谢病且有IgE介导的超敏反应记录的成年患者成功实现对伊米苷酶的快速脱敏。
J Allergy Clin Immunol Pract. 2015 Jul-Aug;3(4):624-6. doi: 10.1016/j.jaip.2014.11.013. Epub 2015 Jan 15.
6
Desensitization for drug hypersensitivity.药物过敏的脱敏治疗。
J Allergy Clin Immunol. 2008 Sep;122(3):581-2. doi: 10.1016/j.jaci.2008.07.020.
7
Successful desensitization of elosulfase alfa-induced anaphylaxis in a pediatric patient with Morquio syndrome.成功脱敏治疗一名患有黏多糖贮积症IV型的儿科患者的阿加糖酶α诱导的过敏反应。
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1156-1157. doi: 10.1016/j.jaip.2017.02.020.
8
Successful desensitization of a patient with Fabry disease with agalsidase beta (Fabrazyme) anaphylaxis after omalizumab pretreatment.在奥马珠单抗预处理后，对患有法布里病且出现β-半乳糖苷酶（法布赞）过敏反应的患者成功进行脱敏治疗。
Ann Allergy Asthma Immunol. 2021 Jan;126(1):96-98. doi: 10.1016/j.anai.2020.08.026. Epub 2020 Aug 29.
9
Laronidase desensitization during stem cell transplant in a child with Hurler syndrome.在一名患有Hurler综合征的儿童进行干细胞移植期间进行拉罗尼酶脱敏治疗。
Ann Allergy Asthma Immunol. 2016 Apr;116(4):377-8. doi: 10.1016/j.anai.2016.01.023. Epub 2016 Feb 23.
10
Rapid desensitization of hypersensitivity reactions to chemotherapy agents.化疗药物超敏反应的快速脱敏
Curr Drug Saf. 2006 Aug;1(3):243-51. doi: 10.2174/157488606777934413.

引用本文的文献

1
How to manage hypersensitivity reactions to enzyme replacement therapy in lysosomal storage diseases?如何应对溶酶体贮积症中酶替代疗法的超敏反应？
Orphanet J Rare Dis. 2025 Jun 6;20(1):287. doi: 10.1186/s13023-025-03844-8.
2
Hematopoietic stem cell transplantation in pediatric patients with type VI mucopolysaccharidosis.VI型黏多糖贮积症患儿的造血干细胞移植
Clin Exp Pediatr. 2025 Aug;68(8):601-607. doi: 10.3345/cep.2024.02033. Epub 2025 Mar 11.